1. Market Research
  2. > Spinal Cord Disorders - Pipeline Review, H2 2013

Spinal Cord Disorders - Pipeline Review, H2 2013

  • September 2013
  • -
  • Global Markets Direct
  • -
  • 31 pages

Spinal Cord Disorders - Pipeline Review, H2 2013

Summary

Global Markets Direct’s, 'Spinal Cord Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Spinal Cord Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Spinal Cord Disorders. Spinal Cord Disorders - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Spinal Cord Disorders.
- A review of the Spinal Cord Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Spinal Cord Disorders pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Spinal Cord Disorders.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Spinal Cord Disorders pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table Of Contents

Spinal Cord Disorders - Pipeline Review, H2 2013
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Spinal Cord Disorders Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Spinal Cord Disorders 7
Spinal Cord Disorders Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Discovery and Pre-Clinical Stage Products 11
Comparative Analysis 11
Spinal Cord Disorders Therapeutics - Products under Development by Companies 12
Companies Involved in Spinal Cord Disorders Therapeutics Development 13
Scil Technology Gmbh 13
Isotechnika Pharma Inc. 14
Daewoong Pharmaceutical Co., Ltd. 15
Omeros Corporation 16
Spinal Cord Disorders - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Molecule Type 18
Drug Profiles 20
DWP-431 - Drug Profile 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
KUR-115 - Drug Profile 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
GPR161 Antagonist - Drug Profile 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
ST-01 - Drug Profile 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
Nonimmunosuppressive Cyclosporin Analog Molecule Program - Drug Profile 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
Spinal Cord Disorders Therapeutics - Drug Profile Updates 26
Spinal Cord Disorders Therapeutics - Dormant Products 27
Spinal Cord Disorders - Product Development Milestones 28
Featured News and Press Releases 28
Dec 17, 2012: Genervon Receives Notice From European Patent Office For Patents On Methods Of Treating Neuronal Disorders Using MNTF Peptides And Analogs Thereof 28
Nov 10, 2011: Seikagaku Announces Start Of Phase III Trial In Japan For SI-6603 28
Aug 10, 2011: Seikagaku Announces Additional Clinical Trial In Japan For SI-6603 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31



List of Tables

Number of Products Under Development for Spinal Cord Disorders, H2 2013 7
Products under Development for Spinal Cord Disorders - Comparative Analysis, H2 2013 8
Number of Products under Development by Companies, H2 2013 9
Comparative Analysis by Late Stage Development, H2 2013 10
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013 11
Products under Development by Companies, H2 2013 12
Scil Technology Gmbh, H2 2013 13
Isotechnika Pharma Inc., H2 2013 14
Daewoong Pharmaceutical Co., Ltd., H2 2013 15
Omeros Corporation, H2 2013 16
Assessment by Monotherapy Products, H2 2013 17
Assessment by Stage and Molecule Type, H2 2013 19
Spinal Cord Disorders Therapeutics - Drug Profile Updates 26
Spinal Cord Disorders Therapeutics - Dormant Products 27



List of Figures

Number of Products under Development for Spinal Cord Disorders, H2 2013 7
Products under Development for Spinal Cord Disorders - Comparative Analysis, H2 2013 8
Products under Development by Companies, H2 2013 9
Late Stage Products, H2 2013 10
Discovery and Pre-Clinical Stage Products, H2 2013 11
Assessment by Monotherapy Products, H2 2013 17
Assessment by Molecule Type, H2 2013 18
Assessment by Stage and Molecule Type, H2 2013 19



Companies Mentioned

Scil Technology Gmbh
Isotechnika Pharma Inc.
Daewoong Pharmaceutical Co., Ltd.
Omeros Corporation

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.